Nuvig Therapeutics is a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases.
Market
Immunomodulatory therapeutics for inflammatory autoimmune diseases
Location
Menlo Park,
California,
USA
Coinvestors
Sanofi Ventures, Blue Owl Healthcare Opportunities, Norwest Venture Partners, B Capital, Leaps by Bayer, Global BioAccess Fund, LOTTE Holdings, Alexandria Venture Investments, abrdn Inc., Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital